← SynDRA
BALOVAPTAN
SynDRA canonical compound SYN0039409 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
| Primary target(s) | AVPR1A | AVPR2 | HTR2B | OXTR |
| Mechanism of action | vasopressin receptor antagonist |
All known targets
Mechanisms of action (all sources)
- AVPR1A ANTAGONIST
- Vasopressin V1a receptor antagonist
- vasopressin receptor antagonist
Cross-references
Synonyms
- RG7314
- RG-7314
- RO-5285119
- RO5285119
- UNII-RAX5D5AGV6
- RAX5D5AGV6
- 8-chloro-5-methyl-1-(4-pyridin-2-yloxycyclohexyl)-4,6-dihydro-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine
- 8-chloro-5-methyl-1-{trans-4-[(pyridin-2-yl)oxy]cyclohexyl}-5,6-dihydro-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine
- Balovaptan [INN]
- Balovaptan [USAN]
- Balovaptan (USAN/INN)
- Balovaptan [USAN:INN]
- SCHEMBL2471320
- SCHEMBL3329710
- SCHEMBL3332136
- CHEMBL4297183
- GTPL10615
- compound 1 [PMID: 31951127]
- DB14823
- SB19643
- Ro-5285119
- BS-14780
- HY-109024
- CS-0030526
- D11476
- 12-chloro-8-methyl-3-[(1r,4r)-4-(pyridin-2-yloxy)cyclohexyl]-2,4,5,8-tetraazatricyclo[8.4.0.0,tetradeca-1(10),3,5,11,13-pentaene
- 4H-(1,2,4)Triazolo(4,3-a)(1,4)benzodiazepine, 8-chloro-5,6-dihydro-5-methyl-1-(trans-4-(2-pyridinyloxy)cyclohexyl)-
- 8-Chloro-5-methyl-1-(trans-4-(2-pyridinyloxy)cyclohexyl)-5,6-dihydro-4H-(1,2,4)triazolo(4,3-a)(1,4)benzodiazepine
- بالوواپتان
Look up BALOVAPTAN in the interactive SynDRA portal →